<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"efficiency":1,
"fine needle":2,
"nodule":1,
"one-stop thyroid nodule clinic":1,
"surgeon-performed":1,
"thyroid":46,
"Genomic instability":1,
"Proliferation":7,
"Rb-deficient cancers":1,
"Retinoblastoma":1,
"Survival pathways":1,
"Case report":4,
"Giant cell tumor":2,
"Larynx":2,
"Thyroid cartilage":1,
"Desmoplastic stroma reaction":1,
"Follicular thyroid cancer":2,
"HIF-1α":1,
"Hypoxia-associated proteins":1,
"Metastasis":16,
"Tenascin":1,
"Costal cartilage":1,
"Free flap":1,
"Thyroid cancer":64,
"Trachea":2,
"Tracheal reconstruction":1,
"Alcohols":1,
"Cancer":22,
"Cohort studies":2,
"Meta-analysis":11,
"Neoplasms":5,
"Quality of life":4,
"Surveys and questionnaires":1,
"Thyroid gland":5,
"Thyroid neoplasms":21,
"Validation studies":1,
"BRAF":4,
"Kirsten rat sarcoma":1,
"MET":2,
"anaplastic lymphoma kinase":1,
"epidermal growth factor receptor":2,
"non-small cell lung carcinoma":2,
"Carcinoma":4,
"Fine needle aspiration (FNA)":1,
"Indeterminate":2,
"Percutaneous":1,
"intravenous contrast agents":1,
"laser":2,
"lymphatic":1,
"metastases":4,
"ultrasound":15,
"AMAP1":1,
"CCL18":1,
"PITPNM3":1,
"Pyk2":1,
"breast cancer":25,
"Hashimoto’s thyroiditis":2,
"Papillary thyroid carcinoma":52,
"TSH":1,
"Thyroid cytology":3,
"Thyroid nodules":21,
"BRAF V600":1,
"Dabrafenib":1,
"Japanese":1,
"Malignant melanoma":1,
"Mutation":4,
"Solid tumor":1,
"Central lymph node dissection":1,
"Central lymph node metastasis":3,
"Papillary thyroid microcarcinoma":4,
"Cervical lymph nodes":1,
"Shear wave elastography":1,
"Ultrasonography":17,
"Anaplastic thyroid cancer":5,
"Anti-angiogenic inhibitor":1,
"Gastrointestinal perforation":1,
"Lenvatinib":7,
"Tyrosine kinase inhibitor":10,
"Central hyperthyroidism":1,
"Hyperthyroidism":4,
"Pituitary tumors":1,
"TSH-secreting pituitary adenoma":1,
"Thyrotropinoma":1,
"elastography":3,
"thyroid neoplasm":8,
"thyroid nodule":24,
"thyroid/parathyroid":3,
"differentiated radioiodine":1,
"refractory":1,
"Calcitonin":5,
"lung":2,
"medullary carcinoma":1,
"neuroendocrine tumor":2,
"Follicular variant of papillary thyroid carcinoma":2,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":3,
"Thyroid biopsy":2,
"Thyroid fine needle aspiration cytology":1,
"Thyroid histopathology":1,
"Thyroid ultrasound":3,
"Brain metastasis":1,
"Malignant glioma":1,
"Therapeutic anticoagulation":1,
"Venous thromboembolism":1,
"adipokine":1,
"cytokine":1,
"inflammation":1,
"prospective cohort":1,
"Cancer stem cell":1,
"Doxorubicin resistance":1,
"PRMT5":1,
"brown tumor":2,
"core biopsy":1,
"cytology":11,
"fine needle aspiration":7,
"hyperparathyroidism":2,
"renal cell carcinoma":1,
"Bethesda":2,
"indeterminate cytology":2,
"repeat FNA":1,
"unsatisfactory":1,
"incidence":9,
"medical overuse":1,
"overdiagnosis":2,
"screening":3,
"anaplastic thyroid carcinoma":5,
"posterior reversible encephalopathy syndrome":1,
"American Thyroid Association (ATA) guidelines":1,
"fine-needle aspiration cytology (FNAC)":1,
"Superb microvascular imaging":1,
"Bethesda system":3,
"thyroid ultrasonography":1,
"F18-choline":1,
"MIBI SPECT/CT":1,
"Minimally invasive surgery":1,
"PET/CT":5,
"Parathyroid adenoma":3,
"Primary hyperparathyroidism":4,
"2015 American Thyroid Association management guideline":1,
"Thyroid Imaging Reporting and Data System":2,
"artificial intelligence":1,
"computer-aided diagnosis system":1,
"Greece":1,
"Pathology":6,
"Registry":1,
"endoscopic thyroidectomy (ET)":1,
"gas-liquid mixing":1,
"tumescent solution":1,
"ESRP1":1,
"Metabolic gene expression":1,
"Mitochondrial DNA copy number":1,
"Mitochondrial DNA sequence imbalance":1,
"Triple negative breast cancer":1,
"Chernobyl":1,
"Cribriform morular":1,
"Radiation":4,
"Variant":1,
"African American":1,
"Hispanic American":1,
"Medicaid":1,
"North American Indian":1,
"insurance coverage":1,
"multivariate analysis":1,
"papillary carcinoma":7,
"tomography":1,
"differentiated thyroid cancer":11,
"postoperative period":1,
"prognosis":16,
"radioiodine therapy":4,
"time factors":1,
"treatment outcome":1,
"genetics":2,
"molecular diagnosis":2,
"EMT":2,
"FBW7":1,
"Migration and invasion":2,
"NSCLC":1,
"Snail":1,
"hypocalcemia":1,
"hypoparathyroidism":1,
"parathyroid glands":1,
"saline injection":1,
"thyroidectomy":19,
"CK-19":1,
"Galectin-3":3,
"Gene expression":5,
"HBME-1":1,
"Immunohistochemistry":13,
"PIWIL2":1,
"Cancer cells":1,
"PPARγ agonist":1,
"PPARγ antagonist":1,
"Therapeutic agents":1,
"Tumorigenicity":1,
"papillary thyroid cancer":13,
"precision medicine":1,
"radioactive iodine":6,
"refractory thyroid cancer":1,
"risk stratification":1,
"Cowden syndrome":1,
"FGF23":1,
"FN1-FGFR1":1,
"PTEN":1,
"Phosphaturic mesenchymal tumor":1,
"Tumor-induced osteomalacia":1,
"MEN2 syndrome":1,
"RET gene polymorphisms":1,
"associations analysis":1,
"haplotypes":1,
"medullary thyroid carcinoma":10,
"anaplastic":1,
"bias":1,
"continental population groups":1,
"ethnic groups":1,
"health care disparities":1,
"poverty":1,
"radiotherapy":6,
"thyroid carcinoma":17,
"Drug target":1,
"Grainyhead":1,
"Hepatocellular carcinoma":7,
"Oncogene":3,
"Stem cells":1,
"Liver cancer":2,
"Liver fibrogenesis":1,
"Thyroid hormone":1,
"Tumor microenvironment":4,
"Clinical outcome":1,
"Fast track cancer programs":1,
"Prospective study":1,
"Survival":7,
"Thyroid epidemiology":1,
"Cure models":1,
"Net survival":1,
"Probability of being cured":1,
"Time-to-cure":1,
"Eosinophilic abscess":1,
"Mastermind-like transcriptional coactivator 2":1,
"Salivary":1,
"Sclerosing mucoepidermoid carcinoma with eosinophilia":2,
"Microwave":1,
"Thermal ablation":2,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"iodide transporters":1,
"iodine":1,
"iodine metabolism":1,
"sodium iodide symporter (NIS)":1,
"NIFTP":5,
"molecular tests":1,
"risk of malignancy":3,
"RAS":2,
"biomarker":3,
"encapsulated follicular variant papillary thyroid carcinoma":1,
"American Indian/Alaska Native":1,
"cancer surveillance":1,
"health disparities":1,
"Fine needle aspiration cytology":3,
"Head and neck cancer":2,
"Oropharyngeal squamous cell carcinoma":2,
"P16 positive":1,
"Thyroid metastasis":1,
"FNA":4,
"direct smears":1,
"molecular testing":1,
"the Bethesda System":1,
"curved borders":1,
"infiltrative-type expansion":1,
"irregular borders":1,
"jagged edge":1,
"clinicopathological feature":1,
"columnar cell variant":1,
"paraneoplastic hyperthyroidism":1,
"β-hCG":1,
"PAX-8":1,
"ectopic":1,
"squamous cell carcinoma":6,
"thyroglobulin":7,
"thyrotropin":2,
"Elongated quinary patterns":1,
"Higher order spectra":1,
"Particle swarm optimization":1,
"Support vector machine":1,
"local anaesthesia":1,
"non-diagnostic sample":1,
"sedation":1,
"Ligament of Berry":1,
"laryngeal":1,
"nerve":1,
"recurrent":1,
"oncology":4,
"psychosocial distress":1,
"quality of care":1,
"anti-Müllerian hormone":1,
"ionizing radiation":1,
"ovarian reserve":1,
"Ecografía tiroidea":1,
"Nódulo tiroideo":1,
"TI-RADS":2,
"Tiroidectomía":1,
"tumor profiling":1,
"Cancer du sein":1,
"Graves’ disease":3,
"Hyperthyroïdie":1,
"Maladie de Basedow":1,
"Thyroxine":2,
"Triiodothyronine":1,
"Multifocality":1,
"Tumor foci":1,
"RFA":1,
"cystic nodule":1,
"nodule shrinkage":1,
"toxic nodule":1,
"Granular cell tumor":1,
"Pituicytoma":1,
"Posterior pituitary tumor":1,
"Spindle cell oncocytoma":1,
"WHO classification of endocrine tumors":1,
"Case series":1,
"Pediatric":2,
"Tracheal paraganglioma":1,
"PKM2":3,
"SREBP-1a":1,
"cell proliferation":5,
"gene transcription":1,
"lipid metabolism":1,
"lipid synthesis":1,
"lipogenesis":1,
"pyruvate kinase":1,
"sterol regulatory element–binding protein":1,
"Head and neck tumors":1,
"Heavy metals":1,
"Oncogenesis":1,
"PCB":1,
"Diagnostic":2,
"individualized":1,
"signature":1,
"MiR-577":1,
"Rab25":1,
"epithelial-mesenchymal transition":3,
"Dose-escalation":1,
"IMRT":1,
"Locally advanced differentiated thyroid cancer":1,
"Medullary thyroid cancer":5,
"Characteristics":1,
"Intracystic papillary carcinoma":1,
"suppressors of cytokine signaling 1":1,
"6PGD":1,
"NDAH":1,
"NDAPH":1,
"Physcion":1,
"SIRT1":1,
"BRAF mutation":4,
"CD56":2,
"CK19":1,
"papillary thyroid micro-carcinoma":1,
"thyroid peroxidase":2,
"Epidemiology":3,
"serum AMPD1":1,
"oncology nurse":1,
"Docking":1,
"Focused library":1,
"RET kinase":1,
"Virtual screening":1,
"BRAF-activated non-protein coding RNA":2,
"Raf":1,
"extracellular-signal-regulated protein kinase":1,
"mitogen-activated protein kinase kinase":1,
"HRAS proto-oncogene":1,
"case-control":1,
"intron":1,
"variants":1,
"Neuroendocrine carcinoma":2,
"Poorly differentiated":1,
"Small cell lung carcinoma":1,
"p16":1,
"Computer-assisted":1,
"Pattern recognition":1,
"Radionuclide imaging":1,
"Echogenic areas":1,
"Bethesda classification":1,
"atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS)":1,
"fine-needle aspiration cytology":2,
"follicular neoplasm (FN)/suspicious for follicular neoplasm (SFN)":1,
"malignancy risk":2,
"metastatic lesions to the brain":1,
"predictive factors":1,
"whole-brain radiotherapy alone":1,
"Kuma Hospital":1,
"active surveillance":5,
"papillary microcarcinoma":1,
"complication":1,
"elderly":1,
"mortality":2,
"JARID1A":1,
"KDM5A":1,
"epigenetics":2,
"genetically engineered mouse models":1,
"metastatic angiosarcoma":1,
"Antiangiogenic":1,
"VEGF":1,
"VEGFR":1,
"nephropathy":1,
"proteinuria":1,
"renal failure":1,
"salivary gland cancer":1,
"toxicity":1,
"NTRK gene fusions":1,
"TRKA":1,
"TRKB":1,
"TRKC":1,
"neurotrophin":1,
"Cervical oesophageal cancer":1,
"Complete block":1,
"Directional block":1,
"Helical tomotherapy":1,
"Intensity-modulated radiation therapy":2,
"Lung dose":1,
"neoplasm metastasis":3,
"TNM staging":1,
"lymph node":1,
"Fibrinogen":1,
"Lymph node metastasis":5,
"Recurrence":4,
"Cell cycle progression":1,
"Paired box gene 8 (PAX8)":1,
"Papillary thyroid carcinoma (PTC)":1,
"miR-144-3p":1,
"ERBB1":1,
"ERBB2":1,
"MTC":1,
"immunofluorescence":1,
"parafollicular C cells":1,
"secretory granules":1,
"transmission electron microscopy":1,
"ultrastructure":1,
"Breast":1,
"131Iodine whole-body scan":1,
"differentiated thyroid carcinoma":5,
"Metabolic bone disease":1,
"metabolic superscan":1,
"thyrotoxicosis":1,
"ER oestrogen receptor":1,
"ER+ ER positive":1,
"ER− ER negative":1,
"GSL glucosinolate":1,
"ITC isothiocyanate":1,
"PR progesterone receptor":1,
"PR+ PR positive":1,
"PR− PR negative":1,
"Case–control studies":1,
"Cruciferous vegetables":1,
"Glucosinolates":1,
"Isothiocyanates":1,
"checkpoint inhibitor":1,
"hypothyroidism":3,
"risk factor":3,
"sunitinib":1,
"endocrine tumours":1,
"betel quid":1,
"centenarians":1,
"dietary":1,
"lifestyle":1,
"nut":1,
"red meat":1,
"F-18 FDG avidity":1,
"I-131 avidity":1,
"Lung metastasis":4,
"Macronodular":1,
"Micronodular":1,
"18F-Fluorocholine":1,
"18F-Fluorodeoxyglucose":1,
"Cholecystokinin receptor subtype 2":1,
"Minigastrin analogue":1,
"Molecular docking":1,
"focal adhesion kinase":1,
"predictive markers":1,
"tumour progression":1,
"head and neck surgery":3,
"otolaryngology / ENT":1,
"surgery":8,
"surgical oncology":1,
"Cardiac myxoma":1,
"Carney complex":2,
"Thyroid adenoma":1,
"mucin expression":1,
"non-small cell lung cancer":1,
"pancreatic ductal adenocarcinoma":1,
"indolent":1,
"Estrogen":1,
"Estrogen receptors":1,
"SPRED1":1,
"miR-196a":1,
"children":1,
"cytopathology":2,
"head and neck":2,
"Cytokeratin-19":1,
"Hector Battifora mesothelial-1":1,
"malignant":1,
"nonmalignant":1,
"Dehydrated ethanol":1,
"Spontaneously rupture":1,
"TCGA":1,
"kallikreins":1,
"BRAF V600E":2,
"integrated analyses":1,
"microRNA":2,
"transcriptome sequencing":1,
"chemotherapy":3,
"postoperative radiotherapy":1,
"18F-fluorodeoxyglucose positron emission tomography/computed tomography":1,
"Birt–Hogg–Dubé syndrome":1,
"chromophobe renal cell carcinoma":1,
"hurtle cell thyroid cancer":1,
"Minimally invasive":1,
"Peritoneal strumosis":1,
"Struma ovarii":2,
"Carcinoma, papillary":4,
"Extranodal extension":2,
"Ultrasonography, mammary":1,
"digital image analysis":1,
"invasion":5,
"programmed death-ligand 1":2,
"protein biomarker":1,
"Bijeljina":1,
"lymph nodes":2,
"papillary":2,
"bioinformatics":2,
"functional enrichment analysis":1,
"osteosarcoma":2,
"sorafenib":2,
"Epithelial mesenchymal transition":1,
"Interleukin-11":1,
"Invasion and metastasis":2,
"Central lymph nodes":1,
"Prelaryngeal lymph nodes":1,
"Superior mediastinum lymph nodes":1,
"Gd–Au NCs":1,
"Glypican-1":1,
"fluorescence imaging":1,
"magnetic resonance imaging":2,
"pancreatic cancer":2,
"CDC73":1,
"HPT-JT":2,
"early onset":1,
"large genomic deletion":1,
"mastectomy":1,
"synchronous cancer":1,
"Helicobacter pylori":1,
"Lymphoma":3,
"Neoplasms, multiple primary":1,
"apoptosis":6,
"metformin":2,
"nude rats":1,
"lateral cervical lymph node metastasis":1,
"lymph node jump metastasis":1,
"collagen triple helix repeat containing 1":1,
"carbon nanoparticles":1,
"risk factors":2,
"younger patients":1,
"American Thyroid Association":1,
"guidelines":1,
"microPLIC":1,
"microPTC":1,
"adrenal insufficiency":1,
"hypopituitarism":1,
"pituitary carcinoma":1,
"pituitary surgery":1,
"prolactinoma":1,
"active surveillance (AS)":1,
"Laryngectomy":2,
"Neck dissection":2,
"Choroid":1,
"ciliary body":1,
"eye":1,
"iris":1,
"uvea":1,
"Abdominal ultrasound":1,
"positron-emission tomography/computed tomography scan":1,
"primary Choroidal melanoma":1,
"staging":2,
"Dysthyroidism":1,
"Tyrosine kinase inhibitors":3,
"H-FLAC":1,
"L-FLAC":1,
"fetal adenocarcinoma":1,
"lung cancer":4,
"outcomes":1,
"p53":1,
"Desmoid-type fibromatosis":2,
"calcifications":1,
"histopahology":1,
"tumor":1,
"APCL":1,
"Panobinostat":1,
"Wnt/β-catenin signaling pathway":1,
"4T1 mammary carcinoma":1,
"Respiratory hyperoxia therapy":1,
"T-cell immune-suppression":1,
"hypoxia":1,
"myeloid-derived suppressor cells":1,
"tumor immunity":1,
"cancer risk":2,
"colorectal cancer":2,
"levothyroxine":3,
"thyroid hormones":1,
"anaplastic carcinoma":1,
"capsule":1,
"carcinosarcoma":1,
"good prognosis":1,
"noninvasive":1,
"Immunomodulation":1,
"Immunotherapy":2,
"Nanoparticles":1,
"Vaccines":1,
"HAX-1":1,
"migration":2,
"Spindle cells":1,
"embryonic remnants":1,
"epithelial-mesenchymal transformation":1,
"multinodular goiter":1,
"German cancer registry data":1,
"Hodgkin lymphoma":2,
"non-Hodgkin lymphoma":1,
"standardized incidence ratio":1,
"subsequent primary malignancies":1,
"nodules":1,
"2SC":1,
"BAP1":1,
"BAP1 hereditary cancer predisposition syndrome":1,
"FAP-associated cribriform-morular variant of papillary thyroid carcinoma":1,
"Familial succinate dehydrogenase-related pheochromocytoma/paraganglioma":1,
"Fumarate hydratase":1,
"Glucagon":1,
"HLRCC":1,
"HRASQ61R":1,
"MEN2":1,
"Mahvash disease":1,
"PRKAR1A":1,
"Pancreatic neuroendocrine tumor syndrome":1,
"Parafibromin":2,
"SDHB":1,
"β-catenin":1,
"radioiodine refractory":1,
"targeted therapy":1,
"Diabetes":2,
"Diet":1,
"Milk":1,
"Obesity":1,
"Second malignancy":1,
"cancer survivorship":1,
"cohort study":1,
"osteoporosis":2,
"Classification":2,
"Indeterminate fine-needle aspiration cytology":1,
"Breast neoplasm":2,
"Estrogen receptor":1,
"Human epidermal growth factor receptor 2":1,
"Ki-67":1,
"Progesterone receptor":1,
"computed tomography scan":1,
"computerized axial tomography scan":1,
"18F-FDG":1,
"2-deoxy-2-(18F)fluoro-d-glucose":1,
"positron emission tomography":2,
"vandetanib":3,
"FDG":1,
"incidentaloma":3,
"benign":1,
"cyst":1,
"fine-needle aspiration":6,
"TSH suppression":2,
"hyperinsulinemic-euglycemic clamp":1,
"insulin sensitivity":1,
"MIVAT":1,
"Scar":1,
"Tips and techniques":1,
"Bilateral axillo-breast approach":1,
"Modified radical neck dissection":1,
"Gynecologic cancer":1,
"Rare cancer":1,
"CASTLE":1,
"EGFR":2,
"EGFR T790M":1,
"sequencing":1,
"thyroiditis":3,
"Genetic markers":1,
"Proto-oncogene":1,
"Cervical lymph node":2,
"Cáncer de tiroides diferenciado":1,
"Disección de ganglios del cuello":1,
"Ganglio cervical":1,
"Metástasis":1,
"Neck lymph node dissection":1,
"Patient Care":1,
"Practice-Based Learning and Improvement":1,
"Systems-Based Practice":1,
"curriculum":1,
"simulation":1,
"CK20":1,
"MCPyV":1,
"Merkel cell carcinoma":2,
"TTF-1":1,
"differential diagnosis":1,
"Anterior pituitary":1,
"Diabetes insipidus":1,
"Glucose metabolism":2,
"Langerhans cell histiocytosis":1,
"operative time":1,
"robotic thyroidectomy":1,
"thyroid surgery":3,
"thyroid tumor":1,
"follicular adenoma":3,
"metaplasia":1,
"spindle cell":1,
"TERT promoter mutation":4,
"Telomerase reverse transcriptase":1,
"IC87114":1,
"PI3K/Akt":1,
"docetaxel":1,
"epirubicin":1,
"neoadjuvant chemotherapy":1,
"recombinant human endostatin (endostar)":1,
"robotic":1,
"transoral":1,
"autophagy":1,
"digitalislike compounds":1,
"hNIS":1,
"radioactive iodide":1,
"apoptos":1,
"cell signaling pathways":1,
"PTC":1,
"SEER":2,
"disease specific survival":1,
"extent of operation":1,
"gasless trans-axillary approach":1,
"outcome":3,
"periodic change":1,
"robotic surgery":2,
"illness perceptions":1,
"interpretative phenomenological analysis":1,
"psychosocial":1,
"support needs":1,
"young people":1,
"AKT2":1,
"Ovarian cancer":4,
"Leiomyosarcoma":1,
"Parotid gland":1,
"Parotidectomy":1,
"Autocrine":1,
"PDGFR α":1,
"Platelet derived growth factor α":1,
"Atypia of undetermined significance":1,
"Bethesda thyroid cytopathology system":1,
"Follicular lesion of undetermined significance":1,
"Papillary features":1,
"Afirma":1,
"atypia of undetermined significance (AUS)":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"subcategory":1,
"FGF19":1,
"FGFR4":1,
"Serum concentration":1,
"βKlotho":1,
"Clinicopathological features":2,
"Lymph node dissection":4,
"Neoplasm recurrence, local":1,
"Thyroid cancer, well differentiated, papillary, follicular":1,
"Tumor staging":2,
"BNCT":1,
"Damage":1,
"Pathways":1,
"Repair":1,
"7-gene test":1,
"atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS)":1,
"diagnostic qualifiers":1,
"thyroid fine-needle aspiration (FNA)":1,
"CXCL5-CXCR2 axis":1,
"Cancer metastasis":1,
"Epithelial-to-mesenchymal transition":1,
"β-catenin signaling":1,
"Contrast-enhanced ultrasound":1,
"Solid hypo-echoic thyroid nodules":1,
"HOTTIP":1,
"Long non-coding RNA":2,
"miR-637":1,
"Nordic registries":1,
"Pregnancy":4,
"endometrial cancer":1,
"Radioresistance":3,
"Stem-like":1,
"Air pollution":1,
"Industrial waste gas":1,
"Shanghai":1,
"Follicular cancer":1,
"Papillary cancer":1,
"incidental":1,
"Italy":1,
"Time trends":1,
"cancer immunoediting":1,
"immune landscape":1,
"next generation sequencing":2,
"annual percent change":1,
"delay adjustment":1,
"early cancer rate estimates by race":1,
"early estimates of cancer incidence rates":1,
"population-based registry data":1,
"TSHR gene mutations":1,
"allelic frequency of TSHR gene mutations":1,
"cancer risks and TSHR mutation":1,
"follicular thyroid cancer and TSHR":1,
"Bexarotene":1,
"cancer prevention":1,
"cancer treatment":1,
"drug resistance":1,
"drug response":1,
"131I treatment":1,
"Contact time restrictions":1,
"Differentiated thyroid cancer (DTC)":1,
"Radiation safety":1,
"Radioiodine clearance":1,
"Radiosensitivity":1,
"cancers":1,
"cataracts":1,
"history of radiology":1,
"tissue reactions":1,
"Lymphoepithelial cyst":1,
"PAX8":2,
"Solid cell nest":1,
"Squamous metaplasia":1,
"Fine-needle biopsy":1,
"Otolaryngology":2,
"anti-thyroglobulin antibodies":2,
"heterophile antibodies":1,
"immunometric assays":1,
"mass spectrometry":1,
"radioimmunoassay":1,
"thyroglobulin in washout":1,
"Image fusion":1,
"Optical camera":1,
"Whole-body scintigraphy":1,
"l-thyroxine":1,
"COX-2":1,
"PD-L1":2,
"resveratrol":2,
"papillary thyroid cancer surgery":1,
"persistent thyroid cancer":1,
"radioiodine":1,
"Cáncer papilar de tiroides":1,
"Factor pronóstico":1,
"Mutación BRAF":1,
"Prognostic factor":1,
"Terapia con (131)I":1,
"Lung adenocarcinoma":1,
"TRIP13":1,
"Thyroid hormone receptor interactor 13":1,
"carcinoembryonic antigen":1,
"lymph node metastases":2,
"medullary":2,
"node dissection":1,
"PDZ and LIM domain 5":1,
"Proteomics":1,
"Body mass index":2,
"height":1,
"weight":2,
"diagnostic category":1,
"Combined merkel cell carcinoma":1,
"Merkel cell polyomavirus":1,
"Papillomavirus":1,
"Polyomavirus":1,
"Squamous carcinoma":1,
"AZD5153":1,
"BRD4":1,
"Molecularly-targeted therapy":1,
"Laryngotracheal reconstruction":1,
"PHACE syndrome":1,
"Subglottic hemangioma":1,
"Encapsulated follicular variant of papillary thyroid carcinoma":1,
"International trends":1,
"thyroid guidelines":1,
"CD147":1,
"cell malignancy":1,
"miR-125a-5p":1,
"Latin America":1,
"trends":1,
"young adults":1,
"The Bethesda System for Reporting Thyroid Cytopathology":2,
"fine-needle aspiration biopsy":1,
"squamous cells":1,
"BRAF- and RAS-like tumors":1,
"DNA methylation":2,
"kallikrein-related peptidases":1,
"prognostic algorithm":1,
"thyroid cancer stratification":1,
"Gene therapy":1,
"Molecular imaging":1,
"Radioactive iodine refractory differentiated thyroid cancer":1,
"Targeted chemotherapy":1,
"PD-1":1,
"celecoxib":1,
"ultrastructural changes":1,
"Bad":1,
"Bax":1,
"Bcl-2":1,
"Benign thyroid nodules":1,
"Cabozantinib":2,
"Metastatic":2,
"Multikinase":1,
"REMS":1,
"Procalcitonin":3,
"Imaging analysis":1,
"Imaging feature":1,
"Imaging pattern":1,
"Nodule size":1,
"Pattern analysis":1,
"Thyroid malignancy":1,
"Tumor size":1,
"thyroid stimulating hormone":2,
"Differentiation":1,
"H2O2":1,
"Iodide uptake":1,
"NKX2 5":1,
"Persistence/recurrence":1,
"thyroid disease":5,
"nicotinamide phosphoribosyltransferase":1,
"reverse transcription-quantitative polymerase chain reaction":1,
"cluster of differentiation 163":1,
"cluster of differentiation 68":1,
"folate receptor β":1,
"macrophage":1,
"follicular thyroid carcinoma":3,
"muscle metastasis":1,
"occult metastasis":1,
"occult thyroid carcinoma":1,
"Lymph node excision":1,
"Hepatocellular carcinoma TGF-β1 HMGCoAR Statins":1,
"MAP Kinase Signaling System":1,
"Proto-Oncogene Proteins B-raf":1,
"mitochondria":1,
"respiratory chain complex I":1,
"Radiofrequency":1,
"Thyroid ablation":1,
"age-related macular degeneration":1,
"national health insurance research database":1,
"Glucose":1,
"Glutamate oxaloacetate transaminase 1":1,
"Glycolysis":2,
"Metabolic regulation":1,
"Redox regulation":1,
"mTOR":1,
"sodium iodide symporter (NIS)/SLC5A5":1,
"Diagnosis":6,
"Frozen section":3,
"Intraoperative consultation of pathology":1,
"Telepathology":1,
"Congenital abnormalities":1,
"Diagnostic errors":1,
"Otorhinolaryngologic surgical procedures":1,
"Pyriform sinus fistula":1,
"Female":1,
"TSH supression therapy":1,
"Follow-up":2,
"Surveillance":1,
"Total thyroidectomy":2,
"cancer epidemiology":1,
"epidemiological methods":1,
"primary thyroid paraganglioma":1,
"treatment":5,
"cadmium":1,
"endocrine disruption":2,
"mechanisms":1,
"RECIST":1,
"systematic review":2,
"Late complication":1,
"Nasopharyngeal carcinoma":2,
"Normal tissue complication probability":1,
"Radiation-induced hypothyroidism":1,
"Calmodulin antagonists":1,
"Sec62 protein":1,
"Trifluoperazine":1,
"endoplasmic reticulum":1,
"tumor therapy":1,
"MPPED2":1,
"carcinogenesis":1,
"tumour suppressor":1,
"Carcinoid tumor":1,
"Diagnosis, differential":1,
"Ovary disease":1,
"Clinicopathological":2,
"Cribriform morular variant":1,
"Molecular feature":1,
"Acute suppurative thyroiditis":1,
"Bacterial infection":1,
"Malignant tumor":1,
"Piriform sinus fistula":1,
"FOXE1":1,
"Gene polymorphism":1,
"Diagnostic test accuracy review":1,
"G protein":1,
"Gnas":1,
"Gsα":1,
"thyroglobulin-Cre":1,
"Republic of Korea":1,
"Ki67":1,
"malignancy":1,
"subtype":1,
"Cosmesis":1,
"double primary cancer":1,
"hybrid-type endoscopic thyroidectomy":1,
"autoimmune thyroid disease":1,
"incidental thyroid carcinoma":1,
"Neoplasm invasion":1,
"MUC1":1,
"extrathyroid extension":1,
"Keywoeds Recurrent laryngeal nerve":1,
"vocal functions":1,
"CCNE2":1,
"CDK6":1,
"CDKN1A":1,
"KIAA0101":1,
"Sp1":1,
"T3-thyrotoxicosis":1,
"functional thyroid carcinoma":1,
"hypercalcemia":2,
"Linc00518":1,
"LncRNA":1,
"MRP1":1,
"MiR-199a":1,
"Multidrug resistance":1,
"thyroid lobectomy":1,
"function recovery":1,
"recurrent laryngeal nerve":2,
"BRAF mutations":1,
"RAS mutations":1,
"infiltrative/diffusing follicular variant of papillary thyroid cancer":1,
"invasive encapsulated follicular variant of papillary thyroid carcinoma":1,
"iodine-metabolizing genes":1,
"papillary thyroid carcinoma with tall cell histology":1,
"prevalence":2,
"Airway Management":1,
"Emergency Medicine":1,
"Malaysia":1,
"Stridor":1,
"Tracheostomy":1,
"neck abscess":1,
"thyroid abscess":1,
"Hemithyroidectomy":2,
"Hashimoto thyroiditis":2,
"Bisphenol":1,
"Endocrine disrupting chemical":1,
"Oral cancer":1,
"Oropharyngeal cancer":1,
"cricoarytenoid unit":1,
"laryngeal cancer":1,
"posterior laryngeal compartment":1,
"surface coils":1,
"Iodine distribution":1,
"nuclear accident":1,
"Cell growth":1,
"Huangqi Fuzheng decoction":1,
"Systems pharmacology":1,
"ESCRT":1,
"Extracellular vesicles":1,
"Human hepatoma":1,
"MVB":1,
"GAS5":1,
"methylation":1,
"triple-negative breast cancer":2,
"CD4":1,
"CD8":1,
"tumor-infiltrating lymphocytes":1,
"CTNNB1 mutations":1,
"desmoid tumor":1,
"β-catenin aberrant staining":1,
"CTC":1,
"circulating biomarkers":1,
"miRNA":2,
"neuroendocrine tumors":2,
"Assistive Device":1,
"Cancer Care":1,
"Falls":1,
"Fatigue":1,
"Patient Safety":1,
"Risk Management":1,
"Couples":1,
"gastric cancer":2,
"quercetin":1,
"uPA receptor":1,
"urokinase plasminogen activator":1,
"Epiphyseal displacement of humerus":1,
"Genu valgum":1,
"Pubertal growth spurt":1,
"Slipped upper femoral epiphysis":1,
"Fatal thyroid cancer":1,
"MLH1":1,
"PDGFRA":1,
"Inadvertent parathyroidectomy":1,
"Incidental parathyroidectomy":1,
"Aspiration technique":1,
"Capillary action":1,
"Non diagnostic rates":1,
"Surgical instruments":1,
"Voice":1,
"Amyloid":1,
"Amyloid goiter":1,
"Parathyroid":2,
"Bethesda III":1,
"Bethesda IV":1,
"follicular neoplasm":1,
"false negative":1,
"false positive":1,
"size":1,
"ultrasound features":1,
"ultrasound-guided fine-needle aspiration":1,
"Dipeptidyl peptidase-IV inhibitor":1,
"Gemigliptin":1,
"PXD101":1,
"Synergism":1,
"Hürthle cell":1,
"cystic thyroid nodule":1,
"ethanol injection":2,
"polidocanol injection":1,
"therapeutic":1,
"Foxp3":1,
"Cancer immunotherapy":2,
"Endocrine adverse events":1,
"Immune checkpoint inhibitors":1,
"Thyroid dysfunctions":1,
"Risk assessment":1,
"Anti-mullerian hormone":1,
"Patient age":1,
"Calcinosis":1,
"Ablation techniques":2,
"High-intensity focused ultrasound ablation":2,
"Induced hyperthermia":1,
"Interventional ultrasonography":2,
"Nodular goitre":2,
"Pain management":1,
"Angiosarcoma":1,
"Dedifferentiated liposarcoma":1,
"Epithelioid sarcoma":1,
"Ewing sarcoma":1,
"Neuroblastoma":1,
"PEComa":1,
"Sarcoma":1,
"Synovial sarcoma":1,
"ERα36":1,
"GRP78":1,
"GRP94":1,
"Adenolipoma":2,
"encapsulated":1,
"follicular":2,
"infiltrative":1,
"invasive":1,
"CNXI":1,
"arrest":1,
"baroreceptor":1,
"cardiac":1,
"etiology":1,
"intraoperative":1,
"spinal accessory nerve":1,
"trigeminocardiac reflex":1,
"vagal":1,
"vagus":1,
"S100A8/A9":1,
"esophageal squamous cell carcinoma":1,
"nasopharyngeal squamous cell carcinoma":1,
"oral squamous cell carcinoma":1,
"thyroid adenocarcinoma":1,
"lytic bone lesions":1,
"FRACTURE":1,
"HEALTH SERVICES RESEARCH":1,
"Adenosine":1,
"CD73":1,
"Extracellular ATP":1,
"NTPDases":1,
"Purinergic signaling":1,
"Thyroid papillary carcinoma":2,
"thyroid cancer survivor":1,
"Kelch-ECH-associating protein-1 (KEAP1)":1,
"NRF2":1,
"antioxidant":1,
"Calcium signaling":1,
"Dose-response":1,
"Harderian gland":1,
"Human health risk assessment":1,
"Mode of action":1,
"lovastatin":2,
"oxythiamine":1,
"transketolase (TKT)":1,
"Second primary cancer":1,
"aging":1,
"chromatin":1,
"histone modification":1,
"ATC":1,
"TGF-α":1,
"cisplatin sensitivity":1,
"in vitro":1,
"in vivo":1,
"miR-144":1,
"follicular carcinoma":3,
"growth kinetics":1,
"tumour growth":1,
"Airborne polychlorinated biphenyls":1,
"HydroxyLated PCBs":1,
"Metabolism of xenobiotics":1,
"Tumor promotion":1,
"Bethesda category IV nodules":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"risk factors for carcinoma":1,
"Central node dissection":1,
"Morbidity":1,
"Neuromonitoring":1,
"Melatonin":1,
"Reactive oxygen species":1,
"p65":1,
"Bone":2,
"Pattern of metastasis":1,
"Skeletal":1,
"Hepatocyte growth factor":1,
"Serine protease inhibitor":1,
"Lymphocyte to monocyte ratio":1,
"Developed world":1,
"Developing world":1,
"Iodine deficiency":1,
"Low-resource setting":1,
"DCLK1":1,
"miR-424":1,
"Second primary female genital cancer":1,
"Astrocyte elevated gene 1":1,
"MicroRNA-625-3p":1,
"Wnt/β-catenin":1,
"c-Jun N-terminal kinase pathway":1,
"anti-thyroglobulin antibody":1,
"TNM":1,
"comparison":1,
"staging systems":1,
"Artifacts":1,
"FNA biopsy":1,
"ectopic thymus":1,
"paediatric patients":1,
"V600E":1,
"biomarkers":3,
"cell blocks":1,
"immunoperoxidase stain":1,
"immunostaining":1,
"molecular":1,
"smears":1,
"American Thyroid Association (ATA)":1,
"fine-needle aspiration (FNA)":2,
"medullary thyroid carcinoma (MTC)":1,
"multiple endocrine neoplasia (MEN) syndrome":1,
"pitfalls":1,
"Aziridonin":1,
"NRF-2/RHOA/ROCK pathway":1,
"Oridonin":1,
"YD0514":1,
"F-18 FDG PET/CT":1,
"visceral fat":1,
"Citología":1,
"Cáncer de tiroides":1,
"Punción-aspiración con aguja fina":1,
"RET":1,
"genetic alteration":1,
"hereditary":1,
"relapse":1,
"review":1,
"sporadic":1,
"BRAFV600E":2,
"PET":2,
"apatinib":1,
"integrin receptor avβ3 imaging":1,
"radioactive iodine-refractory thyroid cancer":1,
"response assessment":1,
"Diagnostic criteria":1,
"Poorly differentiated carcinoma":1,
"Advanced gastric cancer":1,
"Combination chemotherapy":1,
"Oxaliplatin":1,
"Paclitaxel":1,
"Differentially expressed genes":2,
"Gene expression omnibus":1,
"Microarray analysis":1,
"Adenocarcinoma, follicular":1,
"Thyroid neoplasm/diagnosis":1,
"Thyroid neoplasm/genetics":1,
"Atypical parathyroid adenoma":1,
"Parathyroid carcinoma":2,
"Parathyroid hormone":1,
"Asia":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"risk of malignancy (ROM)":1,
"PI3K/Akt signaling pathway":1,
"doxorubicin":1,
"follicular variant of papillary thyroid carcinoma, NIFTP":1,
"papillary thyroid carcinoma with predominant follicular pattern":1,
"Flushing":1,
"Gastrointestinal":1,
"Systemic Mastocytosis":1,
"human":2,
"efficacy":1,
"exploratory analysis":1,
"treatment-emergent hypertension":1,
"RET proto-oncogene":1,
"age-related progression":1,
"germline mutation":1,
"translational medicine":1,
"cancer genome/genetics":1,
"characteristics and pathology of human cancer":1,
"information":1,
"oncogenes and tumor-suppressor genes":1,
"Physician perceptions":1,
"RAS mutation":1,
"fine-needle aspirate":1,
"cervical ultrasound":1,
"diagnostic accuracy":1,
"EIF1AX":1,
"HRAS":1,
"TERT":1,
"hormone receptor":1,
"postmenopausal":1,
"premenopausal":1,
"Cancer types":1,
"Population pharmacokinetics":1,
"Focal nodular hyperplasia":1,
"Hemangioma":1,
"Liver cysts":1,
"Washout":1,
"Survey":1,
"Key words":1,
"ROCK1":1,
"miR-361-5p":1,
"SRC-1":1,
"VEGFC":1,
"lymphatic metastases":1,
"Central lymph node":1,
"Clinicopathological factors":1,
"Connexin 31":1,
"Ginsenoside":1,
"SELECT":1,
"duration of response":1,
"radioiodine-refractory differentiated thyroid carcinoma":1,
"ultrasound imaging":1,
"Denmark":1,
"hereditary medullary thyroid carcinoma":1,
"sporadic medullary thyroid carcinoma":1,
"Organ at risk":1,
"Thyroid dysfunction":1,
"Remnant ablation":1,
"Star artifact":1,
"Therapeutic uses":1,
"LMO7–BRAF":1,
"fusion gene":1,
"Malabsorption":1,
"Neurologic manifestations":1,
"electronic health records":1,
"genetic variation":1,
"genome-wide association study":3,
"hospitals":1,
"humans":1,
"multifactorial inheritance":1,
"phenome-wide association study":1,
"phenotype":1,
"risk":1,
"MAPK signaling pathway":1,
"cell-cycle arrest":1,
"diallyl trisulfide":1,
"depression":1,
"traditional Chinese medicine":1,
"uterine fibroids":1,
"sphingosine kinase 1":1,
"sphingosine-1-phosphate":1,
"sphingosine-1-phosphate receptor 3":1,
"K1 cells":1,
"chaperonin containing TCP1 subunit 3":1,
"B-Raf proto-oncogene serine/threonine kinaseV600E":1,
"MpS1":1,
"phospho-mitogen-activated protein kinases":1,
"differenciált pajzsmirigy-carcinoma":1,
"follicularis":1,
"pajzsmirigy":1,
"papillaris":1,
"radioiodine treatment":1,
"radiojód":1,
"HMGB1":1,
"RAGE":1,
"hepatic resection":1,
"tumor differentiation":1,
"AKT":1,
"PDZ-LIM family":1,
"enigma":1,
"survivin":1,
"Teratoma of the ovary":1,
"papillary renal cell cancer":1,
"X-ray computed tomography":1,
"Cisplatin":1,
"Combination strategies":1,
"Glycolytic pathway":1,
"Inhibitors":1,
"Endocrine disruptor":1,
"Environmental exposures":1,
"Flame retardants":1,
"Women’s health":1,
"Fe3O4 superparticles":1,
"anti-metastasis":1,
"checkpoint blockade therapy":1,
"photothermal-activatable":1,
"endocrine cancer":3,
"immunology":1,
"urological cancer":1,
"EBER ISH":1,
"Epstein-Barr virus":1,
"Lymphoepithelioma-like carcinoma":1,
"Autoimmune gastritis":1,
"Biliary tract cancer":1,
"Leukaemia":1,
"Pernicious anaemia":1,
"Iodine radioisotopes":2,
"bone marrow thyroid neoplasms":1,
"18F-FDG PET/CT Hurthle cell adenoma":1,
"screening (oncology)":1,
"DNAJC8":1,
"HSP40":1,
"glucose transporter":1,
"pyruvate kinase M2":1,
"tazarotene-induced gene 1":1,
"Surgical flaps":1,
"Tracheal defect":1,
"Clinicopathological predictors":1,
"Disease free survival":1,
"Hypoxia inducible factor-1α":1,
"Overall survival":1,
"Prolyl 4-hydroxylase beta polypeptide":1,
"autoimmun thyreoiditis":1,
"autoimmune thyroiditis":1,
"papillaris pajzsmirigy-carcinoma":1,
"thyreoidectomia":1,
"thyreolipoma":1,
"thyrolipoma":1,
"Feature extraction":1,
"TIRADS ultrasound":1,
"Hashimoto’s disease":1,
"Immune checkpoint inhibitor":1,
"Thyroid storm":1,
"Carbon nanoparticle suspension":1,
"Sentinel lymph node biopsy":1,
"dermatology":1,
"breast surgery":1,
"anterior commissure":1,
"laryngeal neoplasms":2,
"lasers":1,
"radiofrequency coblation":1,
"Castleman disease":1,
"fine needle nonaspiration cytology":1,
"laryngostenosis":1,
"surgical procedures,operative":1,
"TAAs":1,
"autoantibody":1,
"survivin lung cancer":1,
"Surgical procedures, operative":1,
"eighth edition of the Union for International Cancer Control TNM Classification of Malignant Tumors":1,
"lymph node density":1,
"multivariate":1,
"CXCR4":1,
"breast carcinoma":1,
"chemokine receptors":1,
"chemokines":1,
"myeloma":1,
"prostate carcinoma":1,
"clinical target volume":1,
"HMGCR":1,
"PPARγ":1,
"RB":1,
"p21cip":1,
"p27cip":1,
"troglitazone":1,
"Kerman":1,
"Clinical characteristics":1,
"Lung neoplasms":1,
"Pulmonary mucoepidermoid carcinoma":1,
"EMC":1,
"KIT":1,
"extraskeletal myxoid chondrosarcoma":1,
"Genetic loci":1,
"Genetic predisposition to disease":1,
"Genetic testing":1,
"Polymorphism, single nucleotide":1,
"Graves disease":1,
"Hashimoto disease":1,
"Thyroid function":1,
"Low-risk":1,
"Micropapillary":1,
"Thyroid cancer, medullary":1,
"Multimodal treatment":1,
"Tracheal perforation":1,
"5 mm":1,
"ultrasonographic":1,
"Cervical mass":1,
"microcarcinoma":1,
"occult thyroid cancer":1,
"Gynecologic cancers":1,
"axillary lymph node":1,
"maximum standardized uptake value":1,
"metachronous":1,
"positron emission tomography/computed tomography":1,
"cytology diagnostic certainty":1,
"endocrine":1,
"endocrine neoplasms":2,
"organ system pathology":2,
"pathology competencies":2,
"clinical features":1,
"cytologic diagnosis":1,
"molecular basis":1,
"pathologic features":1,
"Intensity-modulated radiotherapy":1,
"Progression-free survival":1,
"Highly sensitive thyroglobulin assay":1,
"Neck ultrasound":1,
"TSH-stimulated thyroglobulin test":1,
"C–C motif":1,
"HER2−":1,
"chemokine":1,
"collagen IV":1,
"ligand 5":1,
"luminal B":1,
"quantum dot":1,
"color doppler":1,
"TIRADS":1,
"Acute pancreatitis":1,
"Iodine-refractory thyroid cancer":1,
"Oncological evaluation":1,
"Radioiodine ablation":1,
"ARPP19":1,
"miR-26a":1,
"tamoxifen":1,
"computed tomography (CT)":1,
"incidental findings (IFs)":1,
"low-dose computed tomography (LDCT)":1,
"neoplasm":1,
"Autopsy":1,
"Paired box 8":1,
"humerus fracture":1,
"superior sagittal sinus invasion":1,
"juvenile goiter":1,
"Adrenal Gland Neoplasms":1,
"Single Photon Emission Computed Tomography Computed Tomography":1,
"FoxA1":1,
"FoxA2":1,
"NKX2-1":1,
"cancer biology":1,
"lineage switching":1,
"mouse":1,
"Carcinoma, Neuroendocrine":1,
"Neoplasms, Unknown Primary":1,
"Endotoxin":1,
"Farming":1,
"Pesticides":1,
"fine‐needle aspiration":1,
"multinodular goitre":1,
"Bacterial infections":1,
"Rodentia":1,
"parasitic diseases":1,
"trauma":1,
"long noncoding RNA H19":1,
"long noncoding RNA PTCSC3":1,
"press and release method":1,
"smearing technique":1,
"Autoantibodies":1,
"chronic lymphocytic thyroiditis":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年第2季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
